Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 5/20 | 0.85 |
| ▸ | AVPR2 | P30518 | 4/20 | 0.85 |
| ▸ | AVPR1B | P47901 | 4/20 | 0.85 |
| ▸ | OXTR | P30559 | 3/20 | 0.85 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Desmopressin SCHEMBL22511 | 0.92 | OXTR (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Desmopressin SCHEMBL29387302 | 0.92 | OXTR (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Desmopressin SCHEMBL29454824 | 0.92 | OXTR (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| SCHEMBL23555957 | 0.91 | OXTR (0.72) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Desmopressin SCHEMBL1172203 | 0.91 | OXTR (0.97) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Desmopressin SCHEMBL29935850 | 0.91 | OXTR (0.97) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Desmopressin SCHEMBL1171610 | 0.90 | OXTR (0.96) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Vasopressin SCHEMBL18937546 | 0.90 | AVPR1A (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Vasopressin SCHEMBL19712236 | 0.90 | AVPR1A (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 | |
| Vasopressin SCHEMBL17874853 | 0.90 | AVPR1A (1.00) | AVPR1AAVPR2AVPR1BOXTRPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374897-A1 | Closed-Loop Neuromodulation for the Treatment of Affective Neuropsychiatric Disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-11-14 | — | — | US | claimed |
| EP-4308217-A1 | CLOSED-LOOP NEUROMODULATION FOR THE TREATMENT OF AFFECTIVE NEUROPSYCHIATRIC DISORDERS | The Regents of University of California (US) | 2024-01-24 | — | — | EP | claimed |
| WO-2022235638-A1 | CLOSED-LOOP NEUROMODULATION FOR THE TREATMENT OF AFFECTIVE NEUROPSYCHIATRIC DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-11-10 | — | — | WO | claimed |
| WO-2025111390-A1 | SYSTEMS AND METHODS FOR DIAGNOSING LIKELIHOOD OF GASTROINTESTINAL DISORDERS | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2025-05-30 | — | — | WO | disclosed |
| US-20240374897-A1 | Closed-Loop Neuromodulation for the Treatment of Affective Neuropsychiatric Disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-11-14 | — | — | US | disclosed |
| US-12004535-B2 | Freeze concentration of root- or tuber juice | COÖPERATIE AVEBE U.A. (NL) | 2024-06-11 | — | — | US | disclosed |
| EP-4308217-A1 | CLOSED-LOOP NEUROMODULATION FOR THE TREATMENT OF AFFECTIVE NEUROPSYCHIATRIC DISORDERS | The Regents of University of California (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20240016875-A1 | SHAN-ZHA FOR THE TREATMENT OF DEPRESSION AND ANXIETY DISORDERS | THE OPEN UNIVERSITY (IL) | 2024-01-18 | — | — | US | disclosed |
| CN-117320781-A | Closed-loop neuromodulation for the treatment of affective neuropsychiatric disorders | 加利福尼亚大学董事会 | 2023-12-29 | — | — | CN | disclosed |
| CN-117295508-A | Opioid dosage reduction compositions and methods of use thereof | 迈索布拉斯特国际有限公司 | 2023-12-26 | — | — | CN | disclosed |
| US-20230032781-A1 | FREEZE CONCENTRATION OF ROOT- OR TUBER JUICE | COÖPERATIE AVEBE U.A. (NL) | 2023-02-02 | — | — | US | disclosed |
| WO-2022235638-A1 | CLOSED-LOOP NEUROMODULATION FOR THE TREATMENT OF AFFECTIVE NEUROPSYCHIATRIC DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-11-10 | — | — | WO | disclosed |
| US-11477997-B2 | Freeze concentration of root- or tuber juice | COÖPERATIE AVEBE U.A. (NL) | 2022-10-25 | — | — | US | disclosed |